Skip to content

The Baerveldt Implant. Corneal endothelial changes and tube position.

The Baerveldt Implant. Corneal endothelial changes and tube position. - Baerveldt tube & endothelium

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41928
Enrollment
200
Registered
2014-12-19
Start date
2015-01-27
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma

Interventions

None listed

Sponsors

Oogziekenhuis Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age 18-80 years. Informed consent. Primary open-angle glaucoma, pseudoexfoliative glaucoma, pigmentary glaucoma or normal tension glaucoma.

Exclusion criteria

Exclusion criteria: History of corneal diseases (e.g. Fuchs* endothelial dystrophy, HSV keratitis). Cataract surgery less than 12 months before. History of ocular comorbidity. Functionally monocular patients. Need for glaucoma surgery combined with other ocular procedures or an anticipated need for additional ocular surgery. Best corrected visual acuity less than 0.1. Study eye received Baerveldt implant before. Fellow eye already included in this study.

Design outcomes

Primary

MeasureTime frame
Correlation between endothelial cell counts and tube position.

Secondary

MeasureTime frame
Pachymetry. Cell morphology. Stromal changes. Tube length. Corneal decompensation.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)